{
    "nct_id": "NCT05272462",
    "official_title": "A Phase II Trial of Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer",
    "inclusion_criteria": "Inclusion Criteria\n\n* Participants must have recurrent platinum resistant ovarian cancer. Histologic documentation of the recurrence is not required.\n* Participants must have platinum resistant disease defined as recurrence less than 6 months after initial platinum based treatment.\n* Participants must be greater than or equal to 18 years of age.\n* Participants must have an Eastern Cooperative Group (ECOG) Performance Status (PS) less than or equal to 2.\n* Participants must be able to take oral medications.\n\nExclusion Criteria\n\n* Participants must not have had chemotherapy or radiotherapy within 4 weeks\n* Participants must not be receiving any other investigational agents.\n* Participants must not have brain metastases\n* Participants must not have allergic reactions to minoxidil\n* Participants must not have congestive heart failure\n* Participants must not have history of cardiac disease\n* Participants must not have uncontrolled hypertension\n* Participants must not be on dialysis\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}